Last reviewed · How we verify

NCT07253727: LUCENT

The LUCENT Study - LUng Lesion Assessment Via BF-UCP190F for Central and Extended Nodal Targeting

Not yet recruiting Last updated 28 November 2025
What this trial tests

trial testing No Interventions in Bronchoscopy in 200 participants. Not yet recruiting.

Timeline
1 December 2025
Primary endpoint
31 January 2027
31 August 2028

Quick facts

Lead sponsorOlympus Europe SE & Co. KG
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment200
Start date1 December 2025
Primary completion31 January 2027
Estimated completion31 August 2028

Drugs / interventions tested

Conditions studied

Sponsor

Olympus Europe SE & Co. KG — full company profile →

Who can join

18 and older, any sex, with Bronchoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Olympus BF-UCP190F bronchoscope combines the reach of a thinner bronchoscope with the benefit of real-time ultrasound, enabling direct lesion visualization and sampling deeper into the lung. Following promising first-in-human data, the LUCENT study aims to evaluate the utility feasibility, effectiveness and safety of this device in a multicenter setting, generating real-world evidence to inform broader adoption in global markets.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No Interventions

Trials testing the same drug.

Other recruiting trials for Bronchoscopy

Currently open trials in the same condition.

Other Olympus Europe SE & Co. KG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07253727.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing